arsenic has been researched along with melarsoprol in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 47 (63.51) | 18.7374 |
1990's | 14 (18.92) | 18.2507 |
2000's | 10 (13.51) | 29.6817 |
2010's | 3 (4.05) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aiyedun, BA; Amodu, AA | 1 |
Blair, LS; Campbell, WC | 1 |
Foulkes, JR | 1 |
Buyst, H | 1 |
Bacchi, CJ; Garofalo, J; Goldberg, B; Nathan, HC; Yarlett, N | 1 |
Astier, A; Brun-Buisson, C; Chariot, P; Gherardi, RK; Malapert, D; Schaeffer, A; Vanderstigel, M; Verroust, J | 1 |
Bales, JD; Harrison, SM; Mbwabi, DL; Schecter, PJ | 1 |
Ethier, L; Guern, C; Mansinsa, D; Milord, F; Mpia, B; Pepin, J | 1 |
Baeriswyl, S; Brun, R; Kunz, C | 1 |
Chumo, DA; Muriithi, RM; Mwangi, J; Reardon, MJ; Towett, S; Wellde, BT | 1 |
Abinya, A; Chumo, DA; Dola, S; Mbwabi, D; Reardon, MJ; Siongok, TA; Smith, DH; Wanyama, L; Wellde, BT | 1 |
Dolmans, WM; Ebeling, MC; Veeken, HJ | 1 |
Jennings, FW | 3 |
Guern, C; Milord, F; Pepin, J; Schechter, PJ | 1 |
Coombs, GH; Mottram, JC | 1 |
Kazyumba, GL; Nkanga, N; Ruppol, JF; Tshefu, AK | 1 |
Breton, JC; Dumas, M; Giordano, C; Girard, PL; Pestre Alexandre, M | 1 |
Frommel, TO | 1 |
Akani, F; Boa, FY; Giordano, C; Kouassi, B; Piquemal, M; Sonan, T; Yapi, P | 1 |
Bouteille, B; Darde, ML; Monteil, J; Pestre-Alexandre, M | 1 |
Bouteille, B; Breton, JC; Catanzano, G; Darde, ML; Dumas, M; Munoz, M; Nicolas, JA; Pestre-Alexandre, M | 1 |
Kernbaum, S; Pialoux, G; Vachon, F | 1 |
Doua, F; Hamers, R; Maes, L | 1 |
Cattand, P; Doua, F; Hamers, R; Maes, L; Vanderveken, M | 1 |
Scena, MR | 1 |
Corachán, M; Estruch, R; Grau Junyent, JM; Rozman, M; Urbano-Marquez, A | 1 |
Arroz, JO | 1 |
Adams, H; Dago, A; Haller, L; Merouze, F | 1 |
Dukes, P | 1 |
Breton, JC; Catanzano, G; Dumas, M; Nicolas, JA; Pestre-Alexandre, M | 1 |
Hochmann, A; Lambert, PH; Poltera, AA | 1 |
Hall, JE; Seed, JR; Shertzer, HG | 1 |
Boa Yapo, F; Doua, F | 1 |
Carter, NS; Fairlamb, AH | 1 |
Scott, AG; Tait, A; Turner, CM | 2 |
Barrett, MP; Bertelli, M; Dallocchio, F; Hanau, S; Rippa, M | 1 |
Atouguia, JM; Jennings, FW; Murray, M | 1 |
Gabrilove, JL; Jakubowski, A; König, A; Pandolfi, PP; Rivi, R; Warrell, RP; Wrazel, L | 1 |
Bales, JD; Harris, RW; Harrison, SM | 1 |
Delva, L; Gabrilove, JL; Gambacorti-Passerini, C; König, A; Pandolfi, PP; Rivi, R; Scheinberg, DA; Wang, ZG; Warrell, RP | 1 |
Brouet, JC; Fermand, JP; Labaume, S; Larghero, J; Marolleau, JP; Noguera, MH; Rousselot, P | 1 |
Barrett, MP; Cover, B; de Koning, HP; Jarvis, SM; MacLeod, A | 1 |
Gregus, Z; Gyurasics, A | 1 |
Burri, C; Ericsson, O; Keiser, J | 1 |
Warrell, RP | 1 |
Legros, D; Ollivier, G | 1 |
CECCALDI, J | 1 |
NEUJEAN, G | 1 |
APTED, FI | 1 |
PINTO, AR | 1 |
MICHIELSEN, P; TRIEST, A | 1 |
CARMO, RP; CASEIRO, A; DE BASTO, AX; SILVA, MA | 1 |
EVENS, F; LAMBOTTE, C; LEGRAND, J | 1 |
BURKE, J | 1 |
NIXON, LC; TAUBE, E | 1 |
DE JONGH, RT; FRIEDHEIM, EA | 1 |
HAWKING, F | 1 |
ROBERTSON, DH | 2 |
Barrett, MP; Brun, R; Burchmore, RJ; de Koning, HP; Enyaru, JC; Geiser, F; Kaminsky, R; Mäser, P; Matovu, E; Seebeck, T; Stewart, ML; Wallace, LJ | 1 |
FRIEDHEIM, EA | 1 |
de ALMEIDA, CL; FERREIRA, FS; PIRES, FM | 1 |
Brouet, JC; Chopin, M; Dosquet, C; Fermand, JP; Janin, A; Labaume, S; Larghero, J; Marolleau, JP; Poupon, J; Rousselot, P | 1 |
Bajenova, O; Childs, BH; Feinman, R; Michaeli, J; Pearse, R; Tang, B | 1 |
Schweingruber, ME | 1 |
Alibu, VP; Brun, R; Clayton, C; Marti, G; Renggli, CK; Richter, C; Seebeck, T; Shahi, S; Voncken, F | 1 |
Ajana, I; Astier, A; Gibaud, S | 1 |
Baumann, A; Karst, U; Melles, D; Pfeifer, T | 1 |
Aniceto, N; Astier, A; Becherirat, S; Gibaud, S; Lanhers, MC; Loboda, C; Socha, M; Yemloul, M | 1 |
Francesconi, KA; Magnes, C; Murko, M; Raber, G; Raber, T; Raml, R | 1 |
2 review(s) available for arsenic and melarsoprol
Article | Year |
---|---|
Combination chemotherapy of CNS trypanosomiasis.
Topics: Arsenicals; Central Nervous System Diseases; Drug Therapy, Combination; Humans; Melarsoprol; Nitroimidazoles; Trypanocidal Agents; Trypanosomiasis, African | 1993 |
Arsenicals and inhibitors of histone deacetylase as anticancer therapy.
Topics: Acetylation; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Child; China; Chromatin; Drug Evaluation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gastrointestinal Diseases; Histone Deacetylase Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Melarsoprol; Neoplasm Proteins; Neoplasms; Nervous System Diseases; Oxides; Phenylbutyrates; Protein Processing, Post-Translational; Salvage Therapy; Tretinoin | 1999 |
3 trial(s) available for arsenic and melarsoprol
Article | Year |
---|---|
Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness.
Topics: Administration, Oral; Adolescent; Adult; Aged; Animals; Arsenicals; Child; Child, Preschool; Clinical Trials as Topic; Coma; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Leukocyte Count; Male; Melarsoprol; Middle Aged; Prednisolone; Prognosis; Prospective Studies; Random Allocation; Sex Factors; Trypanosoma brucei gambiense; Trypanosomiasis, African | 1989 |
[Current status of the therapy of human African trypanosomiasis].
Topics: Animals; Arsenicals; Clinical Trials as Topic; Glycolysis; Humans; Lipid Metabolism; Melarsoprol; Proteins; Trypanocidal Agents; Trypanosoma; Trypanosomiasis, African; Vaccines | 1985 |
Attempt to correlate urine arsenic excretion with clinical course during melarsoprol therapy of patients with Rhodesian trypanosomiasis.
Topics: Adolescent; Adult; Aged; Animals; Arsenic; Child; Child, Preschool; Creatinine; Drug Therapy, Combination; Female; Humans; Male; Melarsoprol; Middle Aged; Suramin; Treatment Outcome; Trypanocidal Agents; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 1997 |
69 other study(ies) available for arsenic and melarsoprol
Article | Year |
---|---|
Mel B toxicity in human trypanosomiasis in the Gboko endemic area of Nigeria.
Topics: Adolescent; Adult; Arsenicals; Child; Diarrhea; Female; Fever; Humans; Male; Melarsoprol; Nigeria; Seizures; Trypanosomiasis, African | 1976 |
Chemotherapy of sleeping sickness.
Topics: Arsenicals; Humans; Melarsoprol; Pentamidine; Suramin; Trypanosomiasis, African | 1979 |
Trial of avermectin B1a, mebendazole and melarsoprol against pre-cardiac Dirofilaria immitis in the ferret (Mustela putorius furo).
Topics: Animals; Antinematodal Agents; Arsenicals; Benzimidazoles; Dirofilariasis; Female; Ferrets; Mebendazole; Melarsoprol | 1978 |
An evaluation of prednisolone as a routine adjunct to the treatment of T. rhodesiense.
Topics: Adult; Arsenicals; Child; Drug Administration Schedule; Drug Evaluation, Preclinical; Humans; Melarsoprol; Meningoencephalitis; Prednisolone; Suramin; Trypanosoma; Trypanosomiasis, African; Zambia | 1975 |
The treatment of T. rhodesiense sleeping sickness, with special reference to its physio-pathological and epidemiological basis.
Topics: Arsenicals; Chloroquine; Humans; Melarsoprol; Proguanil; Suramin; Trypanosomiasis, African; Zambia | 1975 |
Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals.
Topics: Animals; Arsenicals; Calcium; Calcium Channels; Drug Resistance; Female; Melarsoprol; Mice; Sulfhydryl Compounds; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1991 |
Organic arsenic-induced Guillain-Barré-like syndrome due to melarsoprol: a clinical, electrophysiological, and pathological study.
Topics: Adult; Arsenic; Arsenic Poisoning; Arsenicals; Diagnosis, Differential; Electrophysiology; Female; Humans; Melarsoprol; Peripheral Nervous System Diseases; Polyradiculoneuropathy; Trypanosomiasis | 1990 |
Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya.
Topics: Adult; Animals; Arsenicals; Drug Therapy, Combination; Eflornithine; Female; Humans; Kenya; Male; Melarsoprol; Middle Aged; Recurrence; Suramin; Trypanosoma brucei brucei; Trypanosomiasis, African | 1989 |
In vitro drug sensitivity of Trypanosoma gambiense isolates.
Topics: Animals; Arsenicals; Cote d'Ivoire; Humans; Melarsoprol; Pentamidine; Suramin; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African | 1989 |
Experimental infection of goats with Trypanosoma brucei ssp. and effects of treatment with suramin and Mel-B.
Topics: Animals; Arsenicals; Brain; Central Nervous System; Central Nervous System Diseases; Goat Diseases; Goats; Male; Melarsoprol; Mice; Spinal Puncture; Suramin; Trypanocidal Agents; Trypanosomiasis, African | 1989 |
Treatment of Rhodesian sleeping sickness in Kenya.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Arsenicals; Child; Drug Resistance; Female; Follow-Up Studies; Humans; Kenya; Male; Melarsoprol; Middle Aged; Prospective Studies; Recurrence; Retrospective Studies; Suramin; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1989 |
Trypanosomiasis in a rural hospital in Tanzania. A retrospective study of its management and the results of treatment.
Topics: Animals; Arsenicals; Female; Follow-Up Studies; Humans; Male; Melarsoprol; Retrospective Studies; Rural Population; Tanzania; Trypanosoma brucei brucei; Trypanosomiasis, African | 1989 |
The potentiation of arsenicals with difluoromethylornithine (DFMO): experimental studies in murine trypanosomiasis.
Topics: Animals; Antimony Sodium Gluconate; Arsenicals; Drug Synergism; Drug Therapy, Combination; Eflornithine; Melarsoprol; Mice; Mitoguazone; Trypanosoma brucei brucei; Trypanosomiasis, African | 1988 |
Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sickness.
Topics: Administration, Oral; Adolescent; Animals; Arsenicals; Child; Child, Preschool; Diarrhea; Drug Resistance; Eflornithine; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Melarsoprol; Recurrence; Trypanosoma brucei gambiense; Trypanosomiasis, African | 1987 |
Leishmania mexicana: enzyme activities of amastigotes and promastigotes and their inhibition by antimonials and arsenicals.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Arsenicals; Citric Acid Cycle; Gluconates; Glycolysis; Hexokinase; Leishmania; Malate Dehydrogenase; Melarsoprol; Organometallic Compounds; Phosphoenolpyruvate Carboxykinase (GTP); Phosphofructokinase-1; Pyruvate Kinase; Triazines | 1985 |
[Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis].
Topics: Arsenicals; Drug Resistance; Eflornithine; Humans; Melarsoprol; Trypanosomiasis, African | 1988 |
Chemotherapy of trypanosomiasis: the potentiation of melarsoprol by concurrent difluoromethylornithine (DFMO) treatment.
Topics: Animals; Arsenicals; Chagas Disease; Drug Synergism; Drug Therapy, Combination; Eflornithine; Melarsoprol; Mice; Trypanosoma brucei brucei | 1988 |
Trypanosoma brucei rhodesiense: effect of immunosuppression on the efficacy of melarsoprol treatment of infected mice.
Topics: Animals; Arsenicals; Cyclophosphamide; Immunosuppression Therapy; Male; Melarsoprol; Mice; Mice, Inbred C3H; Trypanosoma brucei brucei; Trypanosomiasis, African | 1988 |
[EEG and treatment with Arsobal in human African trypanosomiasis].
Topics: Animals; Arsenicals; Electroencephalography; Humans; Melarsoprol; Trypanosoma brucei gambiense; Trypanosomiasis, African | 1988 |
[Complement: a sign of infestation of sheep by Trypanosoma brucei brucei in an experimental model: its evolution following treatment].
Topics: Animals; Arsenicals; Complement System Proteins; Disease Models, Animal; Melarsoprol; Sheep; Trypanosoma brucei brucei; Trypanosomiasis, African | 1988 |
[Treatment of experimental trypanosomiasis caused by Trypanosoma brucei brucei in sheep: study of the minimum active dose of melarsoprol].
Topics: Animals; Arsenicals; Injections, Intravenous; Melarsoprol; Sheep; Trypanosoma brucei brucei; Trypanosomiasis, African | 1988 |
[Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome].
Topics: Adult; Animals; Arsenicals; Brain Diseases; Humans; Male; Melarsoprol; Trypanosoma brucei gambiense; Trypanosomiasis, African | 1988 |
ELISA assay for melarsoprol.
Topics: Arsenicals; Enzyme-Linked Immunosorbent Assay; Humans; Melarsoprol; Methods; Trypanocidal Agents | 1988 |
The monitoring of trypanocidal treatment with a sensitive ELISA method for measuring melarsoprol levels in serum and in cerebrospinal fluids.
Topics: Arsenicals; Chemical Phenomena; Chemistry; Enzyme-Linked Immunosorbent Assay; Humans; In Vitro Techniques; Melarsoprol; Spectrophotometry, Atomic; Trypanosomiasis, African | 1988 |
Melarsoprol toxicity in the treatment of human African trypanosomiasis. Ten cases treated with dimercaprol.
Topics: Adolescent; Adult; Arsenicals; Central Nervous System Diseases; Dimercaprol; Female; Humans; Male; Melarsoprol; Middle Aged; Trypanosomiasis, African | 1988 |
An unusual course of west African trypanosomiasis in a Caucasian man.
Topics: Adult; Arsenicals; Heart Block; Humans; Male; Melarsoprol; Polyradiculoneuropathy; Trypanosomiasis, African | 1987 |
Melarsoprol and reactive encephalopathy in Trypanosoma brucei rhodesiense.
Topics: Arsenicals; Brain Diseases; Humans; Melarsoprol; Trypanosoma brucei brucei; Trypanosomiasis, African | 1987 |
Clinical and pathological aspects of human African trypanosomiasis (T. b. gambiense) with particular reference to reactive arsenical encephalopathy.
Topics: Animals; Arsenicals; Brain Diseases; Humans; Melarsoprol; Seizures; Trypanosoma brucei gambiense; Trypanosomiasis, African | 1986 |
Arsenic and old taxa: subspeciation and drug sensitivity in Trypanosoma brucei.
Topics: Animals; Arsenicals; Diminazene; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Isoenzymes; Male; Melarsoprol; Mice; Pentamidine; Suramin; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1984 |
[Treatment of human African trypanosomiasis].
Topics: Arsenicals; Humans; Melarsoprol; Rifamycins; Trypanosomiasis, African | 1983 |
Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
Topics: Animals; Antigen-Antibody Complex; Arsenicals; Brain; Brain Diseases; Chloroquine; Fluorescent Antibody Technique; Injections, Intraperitoneal; Injections, Intravenous; Melarsoprol; Mice; Nitroimidazoles; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1981 |
Hepatic mixed-function oxidase activity in mice infected with Trypanosoma brucei gambiense or treated with trypanocides.
Topics: Animals; Arsenicals; Cytochrome P-450 Enzyme System; Liver; Male; Melarsoprol; Mice; Mixed Function Oxygenases; Oxidoreductases; Pentobarbital; Sleep; Suramin; Trypanosoma brucei brucei; Trypanosomiasis, African | 1981 |
[Current therapy of trypanosomiasis].
Topics: Adenosylmethionine Decarboxylase; Animals; Arsenicals; Deoxyadenosines; Drug Resistance; Eflornithine; Enzyme Inhibitors; Hospitalization; Humans; Melarsoprol; Pentamidine; Randomized Controlled Trials as Topic; Recurrence; Suramin; Triazines; Trypanocidal Agents; Trypanosomiasis, African | 1994 |
Arsenical-resistant trypanosomes lack an unusual adenosine transporter.
Topics: Adenine; Adenosine; Animals; Antiprotozoal Agents; Arsenicals; Biological Transport; Carrier Proteins; Drug Resistance; Inosine; Kinetics; Melarsoprol; Trypanosoma brucei brucei | 1993 |
Characterisation of cloned lines of Trypanosoma brucei expressing stable resistance to MelCy and suramin.
Topics: Animals; Arsenicals; Biological Assay; Cells, Cultured; Clone Cells; Drug Resistance; Female; Male; Melarsoprol; Mice; Mice, Inbred BALB C; Phenotype; Suramin; Trypanocidal Agents; Trypanosoma brucei brucei | 1996 |
6-Phosphogluconate dehydrogenase from Trypanosoma brucei. Kinetic analysis and inhibition by trypanocidal drugs.
Topics: Animals; Arsenicals; Enzyme Inhibitors; Hydrogen-Ion Concentration; Kinetics; Liver; Melarsoprol; Phosphogluconate Dehydrogenase; Sheep; Species Specificity; Suramin; Trypanocidal Agents; Trypanosoma brucei brucei | 1996 |
The importance of 2,3-dimercaptopropinol (British anti-lewisite, BAL) in the trypanocidal activity of topical melarsoprol.
Topics: Administration, Topical; Animals; Arsenicals; Dimercaprol; Drug Combinations; Female; Gels; Melarsoprol; Mice; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1996 |
Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites.
Topics: Adenine; Adenosine; Animals; Arsenicals; Diminazene; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Female; Inosine; Melarsoprol; Mice; Pentamidine; Trypanocidal Agents; Trypanosoma brucei brucei | 1997 |
Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Cell Division; Cell Line, Transformed; Cell Survival; DNA Damage; DNA Fragmentation; Drug Screening Assays, Antitumor; Herpesvirus 4, Human; Humans; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Melarsoprol; Oxides; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARalpha independent manner.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Bone Marrow Cells; Cell Division; Embryo, Mammalian; Fibroblasts; Gene Expression Regulation; Humans; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Melarsoprol; Mice; Neoplasm Proteins; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Proto-Oncogene Proteins c-bcl-2; Receptors, Retinoic Acid; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins | 1998 |
Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Cell Division; Cell Line; Cell Survival; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Humans; Kinetics; Lymphocyte Activation; Melarsoprol; Multiple Myeloma; Neoplasm Proteins; Nuclear Proteins; Oxides; Plasma Cells; Promyelocytic Leukemia Protein; Transcription Factors; Tumor Suppressor Proteins | 1999 |
Further evidence for a link between melarsoprol resistance and P2 transporter function in African trypanosomes.
Topics: Animals; Antiprotozoal Agents; Arsenicals; Biological Transport, Active; Dose-Response Relationship, Drug; Drug Resistance; Melarsoprol; Mice; Mice, Inbred BALB C; Minisatellite Repeats; Purines; Trypanocidal Agents; Trypanosoma brucei brucei | 2000 |
Role of glutathione in the biliary excretion of the arsenical drugs trimelarsan and melarsoprol.
Topics: Animals; Arsenic; Arsenicals; Biliary Tract; Glucuronic Acid; Glutathione; Liver; Male; Melarsoprol; Rats; Rats, Wistar; Trypanocidal Agents | 2000 |
Investigations of the metabolites of the trypanocidal drug melarsoprol.
Topics: Adult; Animals; Area Under Curve; Arsenic; Arsenicals; Biological Assay; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Interactions; Female; Humans; Male; Melarsoprol; Mice; Mice, Inbred Strains; Microsomes, Liver; Spectrophotometry, Atomic; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosomiasis, African | 2000 |
[Human african trypanosomiasis: A history of its therapies and their failures].
Topics: Arsenicals; Drug Resistance; History, 20th Century; History, 21st Century; Humans; Melarsoprol; Pentamidine; Treatment Outcome; Trypanocidal Agents; Trypanosomiasis, African | 2001 |
[New contribution on arsobal (R.P. 3854) therapy of trypanosomiasis; its effectiveness in former trypanosomiasis patients, with meningoencephalitis, resistant to trypanocides customarily used].
Topics: Animals; Arsenicals; Humans; Melarsoprol; Meningoencephalitis; Trypanocidal Agents; Trypanosomiasis | 1953 |
[Use of arsobal in the treatment of sleeping sickness].
Topics: Animals; Arsenicals; Black People; Humans; Melarsoprol; Trypanosomiasis; Trypanosomiasis, African | 1952 |
The treatment of advanced cases of Rhodesian sleeping sickness by Mel. B. and arsobal.
Topics: Animals; Arsenicals; Black People; Humans; Melarsoprol; Trypanosomiasis; Trypanosomiasis, African | 1953 |
The therapeutic effect on a group of sleeping sickness patients of a single injection of 3854 R.P. (mel B Friedheim-arsobal Spécia).
Topics: Animals; Arsenicals; Humans; Melarsoprol; Trypanosomiasis; Trypanosomiasis, African | 1954 |
[Toxic effects of arsobal on the cardiovascular system].
Topics: Arsenicals; Cardiovascular System; Humans; Melarsoprol | 1954 |
Arsobal in the treatment of Rhodesian sleeping-sickness.
Topics: Animals; Arsenicals; Humans; Melarsoprol; Trypanosomiasis; Trypanosomiasis, African | 1954 |
[A case of trypanosomiasis in an infant treated with arsobal].
Topics: Animals; Arsenicals; Child; Humans; Infant; Melarsoprol; Trypanosomiasis | 1956 |
[Study of the therapeutic value of arsobal in trypanosomiasis caused by Trypanosoma gambiense].
Topics: Animals; Arsenicals; Black People; Humans; Melarsoprol; Trypanosoma brucei gambiense; Trypanosomiasis; Trypanosomiasis, African | 1957 |
The treatment of advanced trypanosomiasis rhodesiense with mel B.
Topics: Animals; Arsenicals; Black People; Humans; Melarsoprol; Trypanosomiasis; Trypanosomiasis, African | 1958 |
Mel W, a new trypanosomicidal agent derived from mel B.
Topics: Arsenicals; Humans; Melarsoprol; Trypanocidal Agents; Trypanosomiasis | 1959 |
Estimation of the concentration of melarsoprol (Mel B) and Mel W in biological fluids by bioassay with trypanosomes in vitro.
Topics: Arsenicals; Biological Assay; Blood; Cerebrospinal Fluid; Humans; In Vitro Techniques; Melarsoprol; Trypanosoma | 1962 |
The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol. I. Reactions observed during treatment.
Topics: Animals; Arsenicals; Dimercaprol; Humans; Melarsoprol; Trypanosoma brucei rhodesiense; Trypanosomiasis; Trypanosomiasis, African | 1963 |
The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol.
Topics: Animals; Arsenicals; Dimercaprol; Humans; Melarsoprol; Trypanosoma brucei rhodesiense; Trypanosomiasis; Trypanosomiasis, African | 1963 |
Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.
Topics: Adenine; Adenosine; Animals; Arsenicals; Benzamidines; Cell Death; Cell Division; Diminazene; Drug Resistance; Female; Gene Silencing; Hypoxanthine; Inhibitory Concentration 50; Inosine; Melarsoprol; Mice; Mutation; Nucleoside Transport Proteins; Pentamidine; Stilbamidines; Trypanosoma brucei brucei | 2003 |
Mel B in the treatment of tryparsamide resistant T. gambiense sleeping sickness: observations on drug resistance in the trypanosomes of the French Cameroun.
Topics: Animals; Arsenic; Arsenicals; Drug Resistance; Humans; Melarsoprol; Trypanosomiasis; Trypanosomiasis, African | 1951 |
[First results of the treatment of human trypanosomiasis with Mel B].
Topics: Arsenic; Humans; Melarsoprol; Trypanosomiasis | 1950 |
Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice.
Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Division; Humans; Immunoglobulin G; Melarsoprol; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Transplantation; Neoplasms, Experimental; Oxides; Plasma Cells; Receptors, Interleukin-6; Survival Analysis; Tissue Distribution; Xenograft Model Antitumor Assays | 2004 |
RIP kinase is involved in arsenic-induced apoptosis in multiple myeloma cells.
Topics: Apoptosis; Arsenic; Caspase 3; Caspases; Cell Division; Cell Line, Tumor; Cell Survival; Enzyme Activation; Humans; Melarsoprol; Multiple Myeloma; NF-kappa B | 2004 |
The melaminophenyl arsenicals melarsoprol and melarsen oxide interfere with thiamine metabolism in the fission yeast Schizosaccharomyces pombe.
Topics: Arsenicals; Culture Media; Melarsoprol; Mutation; Oxides; Pyrimidines; Schizosaccharomyces; Thiamine; Trypanocidal Agents | 2004 |
The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.
Topics: Animals; Arsenicals; Blotting, Western; Cell Line; Electrophoresis, Polyacrylamide Gel; Female; Gene Expression; Humans; Melarsoprol; Membrane Transport Proteins; Mice; Multidrug Resistance-Associated Proteins; Parasitic Sensitivity Tests; Protozoan Proteins; Reverse Transcriptase Polymerase Chain Reaction; Treatment Failure; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2006 |
Arsthinol nanosuspensions: pharmacokinetics and anti-leukaemic activity on NB4 promyelocytic leukaemia cells.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Marrow; Brain; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Melarsoprol; Mice; Mice, Inbred Strains; Nanotechnology; Oxides; Suspensions | 2009 |
Investigation of the biotransformation of melarsoprol by electrochemistry coupled to complementary LC/ESI-MS and LC/ICP-MS analysis.
Topics: Arsenicals; Chromatography, Liquid; Hemoglobins; Humans; Mass Spectrometry; Melarsoprol; Molecular Structure; Protein Binding; Serum Albumin; Trypanocidal Agents | 2013 |
The antitumor effects of an arsthinol-cyclodextrin complex in a heterotopic mouse model of glioma.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; beta-Cyclodextrins; Brain Neoplasms; Cell Line, Tumor; Excipients; Female; Glioma; Humans; Injections, Intraperitoneal; Magnetic Resonance Spectroscopy; Melarsoprol; Mice; Mice, Nude; Oxides; Xenograft Model Antitumor Assays | 2013 |
Determination of the trypanocidal drug melarsoprol and its conversion products in biological fluids with HPLC-ICPMS/ESMS.
Topics: Arsenic; Arsenicals; Biotransformation; Blood Cells; Blood Proteins; Cells, Cultured; Chromatography, High Pressure Liquid; Drug Stability; Humans; Limit of Detection; Melarsoprol; Protein Binding; Serum; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Atomic; Trypanocidal Agents | 2013 |